Simplify Logo

Full-Time

Vice President Quality

Posted on 6/27/2024

Alector

Alector

201-500 employees

Develops immuno-neurology therapies for neurodegenerative diseases

Consulting
Hardware
Biotechnology
Healthcare

Compensation Overview

$333k - $341kAnnually

+ Competitive Compensation

Expert

San Bruno, CA, USA

Category
Public Health
Biology & Biotech
Requirements
  • BS/BA, MS/MA, or PhD in a scientific discipline or related field
  • 15+ years’ experience as a lead in a Quality function with increasing levels of responsibility in the biotech/pharmaceutical industry, including 5+ years’ experience as a Quality Department Head
  • Extensive knowledge of current GxP principles, global regulatory requirements, international guidance documents, quality systems, inspections, and audits
  • Demonstrated leadership and decision-making skills within a Quality organization
  • Proven ability to communicate effectively with employees, senior/executive leadership, Vendors, regulatory authorities, and business partners
  • Significant experience in planning for and hosting regulatory inspections
  • Excellent hands-on experience with implementing and managing phase-appropriate Quality/Compliance systems and processes
  • Extremely detail-oriented with strong organizational skills and high-quality standards
Responsibilities
  • Developing a risk-based Quality strategy
  • Directing, coordinating, creating, and evaluating the activities of the Quality department
  • Implementing process improvements for GxP compliance
  • Providing oversight for Quality Management System components
  • Leading regulatory inspection activities
  • Advising on corrective and preventive action plans
  • Overseeing investigations into quality issues
  • Representing Quality Assurance on cross-functional teams
  • Serving on Joint Steering Committees
  • Developing and managing departmental budget, timelines, and resources

Alector Therapeutics is an excellent workplace for those interested in contributing to cutting-edge therapies in the realm of neurodegenerative diseases. With a focus on immuno-neurology, the company leverages advanced biotechnological methods to pioneer treatments that harness the body’s own immune system for healing. Their robust pipeline of programs in clinical trials demonstrates a commitment to scientific excellence and leadership in addressing complex medical challenges.

Company Stage

IPO

Total Funding

$269.5M

Headquarters

San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

3%

1 year growth

0%

2 year growth

-8%
INACTIVE